NURS-6630C-9/NURS-6630N-9-Approaches to Treatment2020 Spring

NURS-6630C-9/NURS-6630N-9-Approaches to Treatment2020 Spring User Tasiana Malya Course NURS-6630C-9/NURS-6630N-9-Approaches to Treatment2020 Spring Qtr 02/24-05/17-PT27 Test Week 6 Midterm Exam Started 4/1/20 2:00 AM Submitted 4/1/20 3:37 AM Due Date 4/6/20 1:59 AM Status Completed Attempt Score Time Elapsed Results Displayed 72 out of 75 points 1 hour, 36 minutes out of 2 hours Submitted Answers • Question 1 1 out of 1 points Mr. McCullin is 64 years old with Parkinson’s disease. The PMHNP caring for Mr. McCullin wants to start him on a dopamine agonist to help manage and treat his condition. The PHMNP selects this agent because of which action it has on patients like Mr. McCullin? Selected Answer: D. D2 receptors are the primary binding site for dopamine agonists. • Question 2 1 out of 1 points Ms. Hill is currently being treated for schizophrenia but has stopped taking her medications due to some side effects she claims she was experiencing. She presents to the clinic today with worsening symptoms. She is experiencing anhedonia, agitation, attentional impairment, and affective blunting. Which one of the symptoms mentioned is considered a positive symptom of schizophrenia? Selected Answer: B. Agitation • Question 3 1 out of 1 points The PMHNP evaluates the patient for “fear conditioning” when he asks: Selected Answer: A. Have you ever experienced any type of trauma? • Question 4 1 out of 1 points While genes have potential to modify behavior, behavior can also modify genes. How do genes impact this process? Selected Answer: B. Changes made to proteins lead to changes in behavior. • Question 5 1 out of 1 points The PMHNP is caring for a patient with schizophrenia and is considering a variety of treatment approaches. The PHMNP selects a viable treatment that is consistent with the “dopamine hypothesis of schizophrenia.” What action does the PMHNP anticipate this treatment having on the patient? Selected Answer: B. Hyperactivity in the mesolimbic dopamine pathway mediates the positive symptoms of schizophrenia. • Question 6 1 out of 1 points A patient is diagnosed with schizophrenia. What increases the patient’s potential to mediate the cognitive symptoms of the disease? Selected Answer: A. Achieving underactivity of the mesocorticol projections to the prefrontal cortex • Question 7